We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300750:SZSEContemporary Amperex Technology Co., Limited Class A Analysis

Data as of 2026-03-11 - not real-time

CN¥398.77

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Contemporary Amperex Technology (300750.SZ) is trading at 398.77 CNY, comfortably above its 20‑day (360.65) and 200‑day (328.36) moving averages, with a bullish MACD histogram of 4.06 and a rising volume trend, indicating strong short‑term momentum. However, the RSI of 71.2 suggests the stock is approaching overbought territory and the price is flirting with the near‑term resistance at 403.55 CNY. On the valuation side, the current PE of 24.7x sits below the industry average of 29.4x, and a DCF model implies a fair value of 834.6 CNY, offering an upside of roughly 22% versus today’s price.
Fundamentally, the company posted a 36.6% revenue surge, maintains solid margins (gross 26.3%, operating 26.6%) and delivers a robust ROE of 23.8%, while its dividend yield of 1.48% is supported by a low payout ratio of 34%. Analysts collectively rate the stock as a strong buy with median price targets near 500 CNY, and the recent whitepaper on circular‑economy battery recycling underscores favorable industry tailwinds, though the high 30‑day volatility (~35%) and geopolitical exposure to China warrant a measured risk outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at 403.55 CNY
  • High RSI indicating overbought conditions
  • Bullish MACD and increasing volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 36.6% and strong operating margins
  • Undervalued relative to industry PE and DCF upside
  • Analyst consensus strong‑buy with median target ~500 CNY

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Secular demand for EV batteries and recycling solutions
  • Sustainable dividend supported by low payout ratio and robust cash flow
  • Low beta (0.22) indicating limited systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth36.60%
Profit Margin17.04%
P/E Ratio24.7
ROE23.83%
ROA5.76%
Debt/Equity26.26
P/B Ratio5.4
Op. Cash FlowCN¥133.2B
Free Cash FlowCN¥92.0B
Industry P/E29.4

Technical Analysis

TrendBullish
RSI71.2
SupportCN¥334.20
ResistanceCN¥403.55
MA 20CN¥360.65
MA 50CN¥359.70
MA 200CN¥328.36
MACDBullish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair ValueCN¥834.63
Target PriceCN¥489.68
Upside/Downside22.80%
GradeUndervalued
TypeBlend
Dividend Yield1.48%

Risk Assessment

Beta0.22
Volatility35.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.